Floatz logo

Inkt Cells

Pancreatic Cancer

Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineCell therapyN/AActive
D
26/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
59/ 100

Competitive context

372 Active assets in the Pancreatic Cancer cohort.

Asset / SponsorPhaseRating
CIS-DIAMMINEDICHLOROPLATINUM II
Taiho Oncology, Inc.
Phase 3BB
FLUOROURACILUM
Memorial Sloan Kettering Cancer Center
Phase 3BB
Calcium folinate pentahydrate
Memorial Sloan Kettering Cancer Center
Phase 3BB
Eloxatin
Memorial Sloan Kettering Cancer Center
Phase 3BB
Irinotecan
Memorial Sloan Kettering Cancer Center
Phase 3BB

View all 50 →

Same molecule, other indications

Inkt Cells is also rated in:

hepatocellular carcinomaDormant
CCC
Indicative ·
55 / 100
View asset →
Malignant Solid TumorDormant
CCC
Indicative ·
48 / 100
View asset →
Malignant MelanomaDormant
CC
Indicative ·
44 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →